Table 2 Biomarkers and effects on mPower.
From: Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models
|  | mPower | mPower&Slope | λ |
|---|---|---|---|
Biomarker of SHR | \(\frac{{\alpha }^{(p)}}{{\delta }^{(p)}{\beta }^{(p)}}\) | \(\frac{{\alpha }^{(p)}}{{\delta }^{(p)}{\beta }^{(p)}}+\lambda ({\delta }^{(s)}-{m}^{(s)}-{\theta }^{(s)})\) | 0.01 |
Biomarker of WKY | \(\frac{{\delta }^{(p)}{\alpha }^{(p)}}{{\theta }^{(p)}{\beta }^{(p)}}\) | \(\frac{{\delta }^{(p)}{\alpha }^{(p)}}{{\theta }^{(p)}{\beta }^{(p)}}+\lambda ({m}^{(s)}-{\delta }^{(s)})\) | 0.1 |
Biomarker of WIS | \(\frac{{\theta }^{(p)}{\beta }^{(p)}}{{m}^{(p)}{\alpha }^{(p)}}\) | \(\frac{{\theta }^{(p)}{\beta }^{(p)}}{{m}^{(p)}{\alpha }^{(p)}}+\lambda ({\delta }^{(s)}+{\theta }^{(s)}-{m}^{(s)})\) | 0.1 |
Effect of MPH on SHR | \(\frac{{\theta }^{(p)}}{{\delta }^{(p)}{\alpha }^{(p)}}\) | \(\frac{{\theta }^{(p)}}{{\delta }^{(p)}{\alpha }^{(p)}}+\lambda ({m}^{(s)}+{\theta }^{(s)}-{\delta }^{(s)})\) | 0.01 |
Effect of MPH on WKY | \(\frac{{\theta }^{(p)}{\beta }^{(p)}}{{\delta }^{(p)}{\alpha }^{(p)}}\) | \(\frac{{\theta }^{(p)}{\beta }^{(p)}}{{\delta }^{(p)}{\alpha }^{(p)}}+\lambda ({\delta }^{(s)}-{m}^{(s)})\) | 0.01 |
Effect of MPH on WIS | \(\frac{{\theta }^{(p)}}{{\alpha }^{(p)}}\) | \(\frac{{\theta }^{(p)}}{{\alpha }^{(p)}}+\lambda ({m}^{(s)}-{\delta }^{(s)})\) | 0.1 |
Effect of ATX on SHR | \(\frac{{\delta }^{(p)}}{{m}^{(p)}{\beta }^{(p)}}\) | \(\frac{{\delta }^{(p)}}{{m}^{(p)}{\beta }^{(p)}}+\lambda ({\theta }^{(s)}-{\alpha }^{(s)}-{m}^{(s)})\) | 0.01 |
Effect of ATX on WKY | \(\frac{{\delta }^{(p)}}{{m}^{(p)}{\beta }^{(p)}}\) | \(\frac{{\delta }^{(p)}}{{m}^{(p)}{\beta }^{(p)}}+\lambda ({\theta }^{(s)}-{\alpha }^{(s)}-{m}^{(s)})\) | 0.01 |
Effect of ATX on WIS | \(\frac{{\alpha }^{(p)}}{{\theta }^{(p)}{\beta }^{(p)}}\) | \(\frac{{\alpha }^{(p)}}{{\theta }^{(p)}{\beta }^{(p)}}+\lambda ({\theta }^{(s)}-{\alpha }^{(s)}-{m}^{(s)})\) | 0.01 |
